Talking O&G - a RANZCOG Podcast

In this episode of Talking O&G, host Dr Heather Waterfall is joined by Associate Professor Mathew Leonardi to answer RANZCOG members’ and trainees’ questions on endometriosis. An internationally recognised leader in gynaecological surgery and ultrasound, Mathew is an Associate Professor at McMaster University Medical Centre in Hamilton, Canada, and holds a PhD from the University of Sydney. He sits on the World Endometriosis Society Early Career Board and is a founding member of the Next Generation Committee at the International Society of Ultrasound in Obstetrics and Gynaecology. During the discussion, Mathew weighs in on the shift towards ultrasound as the preferred first-line diagnostic tool for endometriosis, the benefits and limitations of this method, how MRI compares, and recommendations for laparoscopy as a surgical intervention. Mathew also advocates for upskilling both gynaecologists and sonographers in advanced gynaecological ultrasound, the importance of ‘prehab’, and how to support patients with endometrioma who are seeking fertility. 🔗 Resources mentioned in this episode: Talking O&G E4. Unpacking RANZCOG’s New Endometriosis Guideline Australian Living Evidence Guideline: Endometriosis Patient resources: https://ranzcog.edu.au/womens-health/endometriosis/ 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity.  In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). COI Statement: Mathew Leonardi reports grants from Australian MRFF, AbbVie, AIMA/SOPHIE, CanSAGE, CIHR, Endometriosis Australia, Hamilton Health Sciences, Health Canada, Hyivy/MITACS/SOPHIE, Medical Research Future Fund/Imagendo, Myant Inc/MITACS, GE HealthCare/MITACS, and Pfizer; honoraria for lectures/writing from AIUM, AbbVie, Bayer, Canon, GE Healthcare, Pfizer, Samsung, TerSera; consultancy work with AbbVie, Chugai, Gesynta, Hologic, Imagendo, Pfizer, and Roche Diagnostics; and affiliations with SUGO (Specialized Ultrasound in Gynecology & Obstetrics) and Endometriosis360. He holds leadership roles in the World Endometriosis Society Early Career Board, ISUOG Next Generation, and the Gynecologic Ultrasound Society, all outside the submitted work.

In this episode of Talking O&G, host Dr Heather Waterfall is joined by Associate Professor Mathew Leonardi to answer RANZCOG members’ and trainees’ questions on endometriosis. An internationally recognised leader in gynaecological surgery and ultrasound, Mathew is an Associate Professor at McMaster University Medical Centre in Hamilton, Canada, and holds a PhD from the University of Sydney. He sits on the World Endometriosis Society Early Career Board and is a founding member of the Next Generation Committee at the International Society of Ultrasound in Obstetrics and Gynaecology. During the discussion, Mathew weighs in on the shift towards ultrasound as the preferred first-line diagnostic tool for endometriosis, the benefits and limitations of this method, how MRI compares, and recommendations for laparoscopy as a surgical intervention. Mathew also advocates for upskilling both gynaecologists and sonographers in advanced gynaecological ultrasound, the importance of ‘prehab’, and how to support patients with endometrioma who are seeking fertility. 🔗 Resources mentioned in this episode: Talking O&G E4. Unpacking RANZCOG’s New Endometriosis Guideline Australian Living Evidence Guideline: Endometriosis Patient resources: https://ranzcog.edu.au/womens-health/endometriosis/ 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity.  In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). COI Statement: Mathew Leonardi reports grants from Australian MRFF, AbbVie, AIMA/SOPHIE, CanSAGE, CIHR, Endometriosis Australia, Hamilton Health Sciences, Health Canada, Hyivy/MITACS/SOPHIE, Medical Research Future Fund/Imagendo, Myant Inc/MITACS, GE HealthCare/MITACS, and Pfizer; honoraria for lectures/writing from AIUM, AbbVie, Bayer, Canon, GE Healthcare, Pfizer, Samsung, TerSera; consultancy work with AbbVie, Chugai, Gesynta, Hologic, Imagendo, Pfizer, and Roche Diagnostics; and affiliations with SUGO (Specialized Ultrasound in Gynecology & Obstetrics) and Endometriosis360. He holds leadership roles in the World Endometriosis Society Early Career Board, ISUOG Next Generation, and the Gynecologic Ultrasound Society, all outside the submitted work.

Preeclampsia is an uncommon yet high-risk condition – especially when it develops early in pregnancy. In this episode of Talking O&G: A RANZCOG Podcast, host Associate Professor Scott White is joined by Professor Amanda Henry and Associate Professor Daniel Rolnik to unpack RANZCOG’s Early Pregnancy Screening and Prevention of Preterm Preeclampsia Guideline. This discussion explores the rationale behind the guideline update, how first-trimester screening improves detection of preeclampsia and practical steps for clinicians. Topics include individualised risk assessment, the Fetal Medicine Foundation (FMF) first-trimester algorithm and the use of aspirin for risk reduction. The guests also discuss equity and access, including barriers faced in rural/remote settings, out-of-pocket costs and culturally competent care for First Nations and Māori patients. 🔗Resources mentioned in this episode: Early pregnancy screening and prevention of preterm preeclampsia and related complications (C-Obs 61) SOMANZ Hypertension in Pregnancy Guideline 2023 FMF Assessment of risk for Preeclampsia (PE) 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

Preeclampsia is an uncommon yet high-risk condition – especially when it develops early in pregnancy. In this episode of Talking O&G: A RANZCOG Podcast, host Associate Professor Scott White is joined by Professor Amanda Henry and Associate Professor Daniel Rolnik to unpack RANZCOG’s Early Pregnancy Screening and Prevention of Preterm Preeclampsia Guideline. This discussion explores the rationale behind the guideline update, how first-trimester screening improves detection of preeclampsia and practical steps for clinicians. Topics include individualised risk assessment, the Fetal Medicine Foundation (FMF) first-trimester algorithm and the use of aspirin for risk reduction. The guests also discuss equity and access, including barriers faced in rural/remote settings, out-of-pocket costs and culturally competent care for First Nations and Māori patients. 🔗Resources mentioned in this episode: Early pregnancy screening and prevention of preterm preeclampsia and related complications (C-Obs 61) SOMANZ Hypertension in Pregnancy Guideline 2023 FMF Assessment of risk for Preeclampsia (PE) 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

Cervical screening is an essential public health measure in the prevention of cervical cancer, and practice continues to evolve with new evidence and recommendations. In this episode of Talking O&G: A RANZCOG Podcast, host Dr Nisha Khot is joined by Associate Professor Jared Watts and Dr Anna Clare to unpack RANZCOG’s new Signposting Guideline: Cervical Cancer Screening in Australia and Aotearoa New Zealand. This discussion covers the rationale for the updated guideline and how it can support clinicians in day-to-day practice. Topics include HPV testing as the primary screening tool, risk-based recommendations, self-collection, and managing higher-risk and immunocompromised groups. The guests also explore approaches to trauma-informed care and guidance for special circumstances such as pregnancy, hysterectomy and non-sexually active patients. They also highlight the importance of culturally safe care, supporting patients to make informed decisions, and what’s next for cervical screening across Australia. While this episode focuses on the Australian context, we’ll be dedicating a future episode to cervical screening in Aotearoa New Zealand.  🔗 Resources mentioned in this episode: RANZCOG Cervical Cancer Screening Guideline RANZCOG Cervical Cancer Screening in Australia and New Zealand Patient Information Pamphlet PREVENT Project 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

Cervical screening is an essential public health measure in the prevention of cervical cancer, and practice continues to evolve with new evidence and recommendations. In this episode of Talking O&G: A RANZCOG Podcast, host Dr Nisha Khot is joined by Associate Professor Jared Watts and Dr Anna Clare to unpack RANZCOG’s new Signposting Guideline: Cervical Cancer Screening in Australia and Aotearoa New Zealand. This discussion covers the rationale for the updated guideline and how it can support clinicians in day-to-day practice. Topics include HPV testing as the primary screening tool, risk-based recommendations, self-collection, and managing higher-risk and immunocompromised groups. The guests also explore approaches to trauma-informed care and guidance for special circumstances such as pregnancy, hysterectomy and non-sexually active patients. They also highlight the importance of culturally safe care, supporting patients to make informed decisions, and what’s next for cervical screening across Australia. While this episode focuses on the Australian context, we’ll be dedicating a future episode to cervical screening in Aotearoa New Zealand.  🔗 Resources mentioned in this episode: RANZCOG Cervical Cancer Screening Guideline RANZCOG Cervical Cancer Screening in Australia and New Zealand Patient Information Pamphlet PREVENT Project 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

Intrahepatic cholestasis of pregnancy (ICP) is the most common liver condition due to pregnancy, yet one that still generates a lot of clinical uncertainty. In this episode, host Dr Nisha Khot speaks with experts, Professor Bill Hague, obstetric physician, and Associate Professor Scott White, obstetrician and maternal fetal medicine specialist. Together they delve into the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) Consensus Statement on Diagnosis and Management of ICP, released in 2023, with the Executive Summary published in ANZJOG. The discussion covers everything from presentation and diagnosis of ICP, management approaches and counselling, the role of ursodeoxycholic acid and alternatives, to timing of birth, monitoring and surveillance, and common misconceptions.   🔗 Resources mentioned in this episode: ANZJOG 2023 – White – Intrahepatic Cholestasis of Pregnancy Contemporary Management Intrahepatic Cholestasis of Pregnancy – Diagnosis and Management   📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733   💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.   The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

Intrahepatic cholestasis of pregnancy (ICP) is the most common liver condition due to pregnancy, yet one that still generates a lot of clinical uncertainty. In this episode, host Dr Nisha Khot speaks with experts, Professor Bill Hague, obstetric physician, and Associate Professor Scott White, obstetrician and maternal fetal medicine specialist. Together they delve into the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) Consensus Statement on Diagnosis and Management of ICP, released in 2023, with the Executive Summary published in ANZJOG. The discussion covers everything from presentation and diagnosis of ICP, management approaches and counselling, the role of ursodeoxycholic acid and alternatives, to timing of birth, monitoring and surveillance, and common misconceptions.   🔗 Resources mentioned in this episode: ANZJOG 2023 – White – Intrahepatic Cholestasis of Pregnancy Contemporary Management Intrahepatic Cholestasis of Pregnancy – Diagnosis and Management 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.   The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G, host Dr Anna Clare (obstetrician gynaecologist) is joined by guest, Dr Tania Day (gynaecologist specialising in vulvovaginal conditions). They discuss the diagnosis, management and ongoing treatment of vulval conditions, particularly lichen sclerosus, is a common yet often under recognised vulval condition that if left untreated can lead to poor outcomes for patients. The conversation explores how vulval condition examination and history taking differs from a standard gynaecological review, approaches to investigations including wet mounts, swabs and PCRs, and why it’s important to consider other disorders of the vulva during your examinations. Dr Tania Day explains why biopsies are an important part of the diagnostic process, why it’s essential to keep your patient informed throughout an examination, and how to navigate management and treatment plans with your patient. The episode discusses how vulval disorders and cancers can be prevented when symptoms are treated early and why it is so important for patients to bring their vulval concerns to their gynaecologist.   🔗 Resources mentioned in this episode: ISSVD Practical Guide to Lichen Sclerosus  O&G Magazine, The Vulva Issue (Winter 2025)  Day & Sobel. Genital cutaneous candidiasis versus chronic recurrent candidiasis: distinct diseases, different populations. Clinical Microbiology Reviews (2025)    📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.  The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). 

In this episode of Talking O&G, host Dr Anna Clare (obstetrician gynaecologist) is joined by guest, Dr Tania Day (gynaecologist specialising in vulvovaginal conditions). They discuss the diagnosis, management and ongoing treatment of vulval conditions, particularly lichen sclerosus, is a common yet often under recognised vulval condition that if left untreated can lead to poor outcomes for patients. The conversation explores how vulval condition examination and history taking differs from a standard gynaecological review, approaches to investigations including wet mounts, swabs and PCRs, and why it’s important to consider other disorders of the vulva during your examinations. Dr Tania Day explains why biopsies are an important part of the diagnostic process, why it’s essential to keep your patient informed throughout an examination, and how to navigate management and treatment plans with your patient. The episode discusses how vulval disorders and cancers can be prevented when symptoms are treated early and why it is so important for patients to bring their vulval concerns to their gynaecologist.   🔗 Resources mentioned in this episode: ISSVD Practical Guide to Lichen Sclerosus  O&G Magazine, The Vulva Issue (Winter 2025)  Day & Sobel. Genital cutaneous candidiasis versus chronic recurrent candidiasis: distinct diseases, different populations. Clinical Microbiology Reviews (2025)    📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.  The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). 

Substance use in pregnancy is a complex and sensitive area of maternity care. In this episode of Talking O&G, host Dr Kasia Siwicki is joined by Dr Anna Clare (obstetrician gynaecologist and Chair of the Guideline Development Group), Dr Dan Wilson (GP and addiction medicine specialist), and Kerri Felemonow (social worker, Manager of The Women’s Alcohol and Drug Service Program at the Royal Women’s Hospital) to unpack the updated RANZCOG Clinical Guideline – Substance Use in Pregnancy (C-Obs 53). The conversation explores why the guideline was updated and what’s new, the role of non-stigmatising, person-centred language, and practical approaches to universal screening in antenatal care. The guests also discuss pharmacological and non-pharmacological supports for nicotine, alcohol, and opioid use, the importance of harm reduction strategies, and what supportive care looks like in practice, with a focus on providing trauma-informed and culturally safe care, particularly for Aboriginal, Torres Strait Islander, and Māori women. The episode investigates how holistic, multidisciplinary and community-led approaches can improve outcomes for mothers and babies. 🔗 Resources mentioned in this episode: Substance Use in Pregnancy (C-Obs 53) 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

Substance use in pregnancy is a complex and sensitive area of maternity care. In this episode of Talking O&G, host Dr Kasia Siwicki is joined by Dr Anna Clare (obstetrician gynaecologist and Chair of the Guideline Development Group), Dr Dan Wilson (GP and addiction medicine specialist), and Kerri Felemonow (social worker, Manager of The Women’s Alcohol and Drug Service Program at the Royal Women’s Hospital) to unpack the updated RANZCOG Clinical Guideline – Substance Use in Pregnancy (C-Obs 53). The conversation explores why the guideline was updated and what’s new, the role of non-stigmatising, person-centred language, and practical approaches to universal screening in antenatal care. The guests also discuss pharmacological and non-pharmacological supports for nicotine, alcohol, and opioid use, the importance of harm reduction strategies, and what supportive care looks like in practice, with a focus on providing trauma-informed and culturally safe care, particularly for Aboriginal, Torres Strait Islander, and Māori women. The episode investigates how holistic, multidisciplinary and community-led approaches can improve outcomes for mothers and babies. 🔗 Resources mentioned in this episode: Substance Use in Pregnancy (C-Obs 53) 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G, host Dr Heather Waterfall is joined by Professor Cindy Farquhar and Dr Marilla Druitt to explore RANZCOG’s newly released Australian Living Evidence Guideline on Endometriosis. Together, they unpack the shift towards earlier, less invasive diagnosis, including the use of transvaginal ultrasound and MRI. The conversation covers first and second-line hormonal treatments, safe use of GnRH therapies, fertility considerations when managing endometriomas, and practical strategies for supporting patients of all ages and backgrounds. This includes targeted recommendations for adolescents and guidance on delivering culturally safe care for First Nations peoples and inclusive, gender-affirming care for gender-diverse people. They also address common misconceptions, including the true cancer risk associated with endometriosis, and highlight the importance of holistic, patient-centred care that combines medical, psychological, and lifestyle support. Whether you work in a metropolitan hospital or regional practice, this episode offers actionable insights to help you apply the latest evidence in diagnosing, managing, and supporting people with endometriosis across Australia and Aotearoa, New Zealand. Written & produced by Rebecca Young for RANZCOG Music by Brendan Jones 🔗 Resources mentioned in this episode: Australian Living Evidence Guideline: Endometriosis 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G, host Dr Heather Waterfall is joined by Professor Cindy Farquhar and Dr Marilla Druitt to explore RANZCOG’s newly released Australian Living Evidence Guideline on Endometriosis. Together, they unpack the shift towards earlier, less invasive diagnosis, including the use of transvaginal ultrasound and MRI. The conversation covers first and second-line hormonal treatments, safe use of GnRH therapies, fertility considerations when managing endometriomas, and practical strategies for supporting patients of all ages and backgrounds. This includes targeted recommendations for adolescents and guidance on delivering culturally safe care for First Nations peoples and inclusive, gender-affirming care for gender-diverse people. They also address common misconceptions, including the true cancer risk associated with endometriosis, and highlight the importance of holistic, patient-centred care that combines medical, psychological, and lifestyle support. Whether you work in a metropolitan hospital or regional practice, this episode offers actionable insights to help you apply the latest evidence in diagnosing, managing, and supporting people with endometriosis across Australia and Aotearoa, New Zealand. Written & produced by Rebecca Young for RANZCOG Music by Brendan Jones 🔗 Resources mentioned in this episode: Australian Living Evidence Guideline: Endometriosis 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G, host Associate Professor Scott White is joined by Dr Clare O’Loughton and Dr Kasia Siwicki to discuss Vasa Praevia, a rare but potentially life-threatening condition that, when diagnosed early, can lead to vastly improved outcomes for both mothers and babies.  Centred around RANZCOG’s new clinical guideline on Vasa Praevia (C-Obs 47), the conversation unpacks the importance of routine screening, the distinction between vasa praevia and low-lying fetal vessels, and how a patient-centred approach to care can support safety, communication, and planning — especially when clinical recommendations must be balanced with personal circumstances. The guests also reflect on the challenges of providing care in rural and remote settings, where access to imaging and specialist input may be limited. Whether you’re based in a hospital or a regional clinic, this episode offers practical insights to help you navigate risk and support patient-centred care.  Written & produced by Rebecca Young for RANZCOG Music by Brendan Jones 🔗 Resources mentioned in this episode: RANZCOG Clinical Guideline: Vasa Praevia (C-Obs 47) 📌 RANZCOG members can submit CPDhttps://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G, host Associate Professor Scott White is joined by Dr Clare O'Loughlin and Dr Kasia Siwicki to discuss Vasa Praevia, a rare but potentially life-threatening condition that, when diagnosed early, can lead to vastly improved outcomes for both mothers and babies.  Centred around RANZCOG’s new clinical guideline on Vasa Praevia (C-Obs 47), the conversation unpacks the importance of routine screening, the distinction between vasa praevia and low-lying fetal vessels, and how a patient-centred approach to care can support safety, communication, and planning — especially when clinical recommendations must be balanced with personal circumstances. The guests also reflect on the challenges of providing care in rural and remote settings, where access to imaging and specialist input may be limited. Whether you’re based in a hospital or a regional clinic, this episode offers practical insights to help you navigate risk and support patient-centred care.  Written & produced by Rebecca Young for RANZCOG Music by Brendan Jones 🔗 Resources mentioned in this episode: RANZCOG Clinical Guideline: Vasa Praevia (C-Obs 47) 📌 RANZCOG members can submit CPDhttps://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G, hosts Dr Heather Waterfall and Dr Nisha Khot are joined by Professor Kirsten Black and Dr Catriona Melville to discuss RANZCOG’s updated clinical guideline on contraception (C-Gyn 3). Adapted from the UK Faculty of Sexual and Reproductive Healthcare guidance, the new guideline offers evidence-based recommendations for delivering safe, effective, and patient-centred contraceptive care across all life stages. We discuss the rationale behind updating the guideline; contraceptive care across the life course, from adolescents to women over 40; the latest advice on quick starting, missed pills, and new progesterone only pills; risk–benefit considerations for combined hormonal contraception; barriers to the uptake of long-acting reversible contraception (LARC); contraceptive options after pregnancy, miscarriage or abortion; inclusive and effective counselling strategies; and common myths and misconceptions, along with what the evidence really says. Written & produced by Rebecca Young  Music by Brendan Jones  🔗 Resources mentioned: RANZCOG Clinical Guideline: Contraception (C-Gyn 3, March 2024) Available at: https://shorturl.at/mWbLs Developed with support from the Faculty of Sexual and Reproductive Healthcare https://www.fsrh.org/ 📌 RANZCOG members can log CPD hours for listening to Talking O&G. 👉 Submit your CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G, hosts Dr Heather Waterfall and Dr Nisha Khot are joined by Professor Kirsten Black and Dr Catriona Melville to discuss RANZCOG’s updated clinical guideline on contraception (C-Gyn 3). Adapted from the UK Faculty of Sexual and Reproductive Healthcare guidance, the new guideline offers evidence-based recommendations for delivering safe, effective, and patient-centred contraceptive care across all life stages. We discuss the rationale behind updating the guideline; contraceptive care across the life course, from adolescents to women over 40; the latest advice on quick starting, missed pills, and new progesterone only pills; risk–benefit considerations for combined hormonal contraception; barriers to the uptake of long-acting reversible contraception (LARC); contraceptive options after pregnancy, miscarriage or abortion; inclusive and effective counselling strategies; and common myths and misconceptions, along with what the evidence really says. Episode written & produced: Rebecca Young  Music by: Brendan Jones  🔗 Resources mentioned: RANZCOG Clinical Guideline: Contraception (C-Gyn 3, March 2024) Available at: https://shorturl.at/mWbLs Developed with support from the Faculty of Sexual and Reproductive Healthcare https://www.fsrh.org/ 📌 RANZCOG members can log CPD hours for listening to Talking O&G. 👉 Submit your CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. This episode of Talking O&G is produced by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). The views expressed are those of the speakers and may not reflect the official position of the College.

In this episode of Talking O&G, host Associate Professor Scott White is joined by Dr Kasia Siwicki, Dr Nicole Liesis and author and co-founder of the Early Pregnancy Loss Coalition, Isy Oderberg to discuss Miscarriage, Recurrent Miscarriage and Ectopic Pregnancy (C-Gyn 38) — RANZCOG’s updated clinical guideline on early pregnancy loss. The episode explores evolving clinical language, updated definitions, and current evidence-based medical and surgical management approaches. The conversation also highlights the importance of psychological support and where care and research are heading next. Written & produced by Rebecca Young Music by Brendan Jones    🔗 Resources mentioned in this episode: RANZCOG Clinical Guideline: Miscarriage, Recurrent Miscarriage and Ectopic Pregnancy (C-Gyn 38) Hard to Bear: Investigating the Science and Silence of Miscarriage - book by Isy Oderberg The Early Pregnancy Loss Coalition 📌 RANZCOG members can log CPD hours via: ⁠CPD Submission Form⁠ 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G, host Associate Professor Scott White is joined by Dr Kasia Siwicki, Dr Nicole Liesis and journalist Isy Oderberg to discuss Miscarriage, Recurrent Miscarriage and Ectopic Pregnancy (C-Gyn 38) — RANZCOG’s updated clinical guideline on early pregnancy loss. The episode explores evolving clinical language, updated definitions, and current evidence-based medical and surgical management approaches. The conversation also highlights the importance of psychological support and where care and research are heading next. Written & produced by Rebecca Young for RANZCOG Music by Brendan Jones    🔗 Resources mentioned in this episode: RANZCOG Clinical Guideline: Miscarriage, Recurrent Miscarriage and Ectopic Pregnancy (C-Gyn 38) Hard to Bear: Investigating the Science and Silence of Miscarriage - book by Isy Oderberg The Early Pregnancy Loss Coalition 📌 RANZCOG members can log CPD hours via: ⁠CPD Submission Form⁠ 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).